H Partners Obtains Clear Referendum for Change at Harley-Davidson's 2025 Annual Meeting
'We thank our fellow shareholders and all other stakeholders, including dealers, riders, and employees, for their outpouring of support during this campaign for change at Harley. While we are disappointed with the state of the Company under the leadership of Mr. Zeitz, Mr. Linebarger, and Ms. Levinson, we believe that this shareholder mandate can create a brighter future for Harley-Davidson.
We are encouraged that this campaign compelled Harley's Board to commit to numerous shareholders that Mr. Zeitz, Mr. Linebarger, and Ms. Levinson will resign from the Board before the 2026 Annual Meeting, that it will appoint a new, external CEO, and that it will eliminate any consideration of Mr. Zeitz remaining on in an Executive Chair role. With such a large withhold vote, we call on the Board to follow through on these promises.
We believe the outcome of today's Annual Meeting sends a clear message that the direction of the Company needs to change. We are pleased that our campaign forced the Board to engage directly with stakeholders that they had long ignored, including dealers, employees, and shareholders. We encourage all stakeholders to continue to voice their perspectives on what is required to fix this great company.'
H Partners Management, LLC is an independent investment firm founded in 2005 based in New York City.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
26 minutes ago
- Yahoo
Luxfer Appoints Stewart Watson to Board of Directors
RIVERSIDE, Calif., August 13, 2025--(BUSINESS WIRE)--Luxfer Holdings PLC (NYSE: LXFR) ("Luxfer" or the "Company"), a global industrial company innovating niche applications of advanced materials, today announced the appointment of Stewart Watson, a UK national, as a Non-Executive Director to its Board, effective September 1, 2025. Upon joining the Board, Mr. Watson will serve on the Nominating and Governance Committee and the Audit Committee. Mr. Watson is a CIMA qualified accountant and a seasoned executive with more than 35 years of leadership experience, including over two decades in the aerospace and defense industry. He spent 23 years at Meggitt PLC, where he held several senior positions, including President of the Meggitt Equipment Group, and served as Divisional Finance Director with responsibility for global operations across the US, UK, Canada, and Spain, including two years working in California. Throughout his career, Mr. Watson has demonstrated expertise in strategic planning, operational transformation, international business leadership, and M&A execution. He currently serves as a Non-Executive Director for two private UK companies - SeaBot Maritime and Poka Audio - and brings valuable governance and strategic advisory experience to the Luxfer Board. "We are pleased to welcome Stewart to the Luxfer Board," said Patrick Mullen, Luxfer's Board Chair. "His deep financial expertise, global operating experience, and proven leadership in complex industrial environments will be a strong asset as we continue to execute our strategy and deliver long-term value for shareholders." Mr. Watson's appointment underscores Luxfer's continued focus on enhancing Board capabilities in support of operational excellence, strategic growth, global expertise, and disciplined capital deployment, while also positioning for the anticipated retirement of a long-standing UK-based board member next year. About Luxfer Holdings PLC Luxfer (NYSE: LXFR) is a global industrial company innovating niche applications in materials engineering. Using its broad array of proprietary technologies, Luxfer focuses on value creation, customer satisfaction, and demanding applications where technical know-how and manufacturing expertise combine to deliver a superior product. Luxfer's high-performance materials, components, and high-pressure gas containment devices are used in defense and emergency response, clean energy, healthcare, transportation, and specialty industrial applications. For more information, please visit View source version on Contacts Kevin Cornelius GrantVice President of Investor Relations and Business Sign in to access your portfolio
Yahoo
26 minutes ago
- Yahoo
ADM to Present at 2025 Barclays Annual Global Consumer Staples Conference
CHICAGO, August 13, 2025--(BUSINESS WIRE)--ADM (NYSE: ADM) will present at the 2025 Barclays Annual Global Consumer Staples Conference on Wednesday, Sept. 3, in Boston. The company will participate in a fireside chat at 1:30 p.m. Eastern Time. The event will be broadcast live at and a replay will also be available for a limited time on About ADM ADM unlocks the power of nature to enrich the quality of life. We're an essential global agricultural supply chain manager and processor, providing food security by connecting local needs with global capabilities. We're a premier human and animal nutrition provider, offering one of the industry's broadest portfolios of ingredients and solutions from nature. We're a trailblazer in health and well-being, with an industry-leading range of products for consumers looking for new ways to live healthier lives. We're a cutting-edge innovator, guiding the way to a future of new bio-based consumer and industrial solutions. And we're leading in business-driven sustainability efforts that support a strong agricultural sector, resilient supply chains, and a vast and growing bioeconomy. Around the globe, our expertise and innovation are meeting critical needs from harvest to home. Learn more at Source: Corporate Release Source: ADM View source version on Contacts ADM Media Relations Jackie Andersonmedia@ 312-634-8484
Yahoo
26 minutes ago
- Yahoo
Afya Limited Announces a New Share Repurchase Program
BELO HORIZONTE, Brazil, August 13, 2025--(BUSINESS WIRE)--Afya Limited (Nasdaq: AFYA; B3: A2FY34) ("Afya" or the "Company"), the leading medical education group and medical practice solutions provider in Brazil, announced today, its Board of Directors has approved a new share repurchase program. Under the share repurchase program, Afya may repurchase up to 4,000,000 of its outstanding Class A common shares, in the open market, based on prevailing market prices, or in privately negotiated transactions, beginning from August 15, 2025 until the earlier of the completion of the repurchase or December 31, 2026, depending upon market conditions. The share purchases may be made from time to time through open market transactions and are subject to market and business conditions, levels of available liquidity, cash requirements for other purposes, regulatory, and other relevant factors. The share repurchase program will take place in accordance with the conditions established by the Board of Directors on August 13, 2025. Afya intends to repurchase the shares for use in its stock option program, consideration in futures business combinations transactions and general corporate purposes. Afya's Board of Directors will review the share repurchase program periodically and may authorize adjustments to its terms and size or suspend or discontinue the program. Afya expects to utilize its existing funds and future dividends to be received from Afya Participações to fund repurchases made under this program. It is Afya's intention that such purchases benefit from the safe harbor provided by Rule 10b-18 ("Rule 10b-18") promulgated by the Securities and Exchange Commission (the "SEC") under the Securities Exchange Act of 1934, as amended. Accordingly, Afya shall not take, nor permit any person or entity under its control to take, any action that could jeopardize the availability of Rule 10b-18 for purchases under the program. About Afya Limited (Nasdaq: AFYA, B3: A2FY34) Afya is a leading medical education group in Brazil based on the number of medical school seats, delivering an end-to-end physician-centric ecosystem that serves and empowers students and physicians to transform their ambitions into rewarding lifelong experiences from the moment they join us as medical students through their medical residency preparation, graduation program, continuing medical education activities and offering medical practice solutions to help doctors enhance their healthcare services through their whole career. View source version on Contacts Investor Relations Contact:Afya Limitedir@
